|
Volumn 29, Issue 4, 1996, Pages 425-433
|
Adjuvant therapy for clinical localized prostate cancer treated with surgery or irradiation
a a a a |
Author keywords
Adenocarcinoma of prostate; Adjuvant treatment; Cyclophosphamide; Definitive irradiation; Estramustine phosphate; Prostate cancer; Radical prostatectomy
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
ESTRAMUSTINE PHOSPHATE;
ESTRAMUSTINE PHOSPHATE SODIUM;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
FOLLOW UP;
HIGH RISK PATIENT;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LYMPH NODE DISSECTION;
MAJOR CLINICAL STUDY;
MALE;
ORAL DRUG ADMINISTRATION;
PELVIS LYMPH NODE;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATECTOMY;
RANDOMIZED CONTROLLED TRIAL;
RELAPSE;
|
EID: 0030004672
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000473791 Document Type: Article |
Times cited : (40)
|
References (0)
|